GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 21, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
7WS8 | Q9BYF1 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WS9 | Q9BYF1 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7WSA | Q9BYF1 | Structures of Omicron Spike complexes illuminate broad-spectrum neutralizing antibody development | |
7ZF7 | Q9BYF1 | SARS-CoV-2 Omicron BA.2 RBD in complex with ACE2 | |
7DX5 | Q9BYF1 | S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (1 up RBD and 1 PD bound) | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
7FDI | Q9BYF1 | SARS-COV-2 Spike RBDMACSp36 binding to hACE2 | |
7KJ4 | Q9BYF1 | SARS-CoV-2 Spike Glycoprotein with three ACE2 Bound | Spike glycoprotein |
6M18 | Q9BYF1 | ACE2-B0AT1 complex | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
6CS2 | Q9BYF1 | SARS Spike Glycoprotein - human ACE2 complex, Stabilized variant, all ACE2-bound particles | Spike glycoprotein,Envelope glycoprotein, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
6VW1 | Q9BYF1 | Structure of SARS-CoV-2 chimeric receptor-binding domain complexed with its receptor human ACE2 | |
7DX4 | Q9BYF1 | The structure of FC08 Fab-hA.CE2-RBD complex | |
7DX7 | Q9BYF1 | Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 1 (1 up RBD and 1 PD bound) | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
7KMB | Q9BYF1 | ACE2-RBD Focused Refinement Using Symmetry Expansion of Applied C3 for Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 7.4 | |
7KMS | Q9BYF1 | Cryo-EM structure of triple ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 | |
7KMZ | Q9BYF1 | Cryo-EM structure of double ACE2-bound SARS-CoV-2 trimer Spike at pH 7.4 | |
7KNB | Q9BYF1 | Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 7.4 | |
7KNE | Q9BYF1 | Cryo-EM structure of single ACE2-bound SARS-CoV-2 trimer spike at pH 5.5 | |
7KNH | Q9BYF1 | Cryo-EM Structure of Double ACE2-Bound SARS-CoV-2 Trimer Spike at pH 5.5 | |
7KNI | Q9BYF1 | Cryo-EM structure of Triple ACE2-bound SARS-CoV-2 Trimer Spike at pH 5.5 | |
7L0N | Q9BYF1 | Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity | |
7MJM | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to human ACE2 ectodomain | Spike glycoprotein, Processed angiotensin-converting enzyme 2 |
7A94 | Q9BYF1 | SARS-CoV-2 Spike Glycoprotein with 1 ACE2 Bound | Spike glycoprotein |
7CT5 | Q9BYF1 | S protein of SARS-CoV-2 in complex bound with T-ACE2 | Spike glycoprotein, heavy chain of 4A8, light chain of 4A8 |
7DX8 | Q9BYF1 | Trypsin-digested S protein of SARS-CoV-2 bound with PD of ACE2 in the conformation 2 (2 up RBD and 2 PD bound) | Sodium-dependent neutral amino acid transporter B(0)AT1, Angiotensin-converting enzyme 2 (E.C.3.4.17.23) |
6LZG | Q9BYF1 | Structure of novel coronavirus spike receptor-binding domain complexed with its receptor ACE2 | |
6M0J | Q9BYF1 | Crystal structure of SARS-CoV-2 spike receptor-binding domain bound with ACE2 | |
7DDO | Q9BYF1 | Cryo-EM structure of human ACE2 and GD/1/2019 RBD | |
7DF4 | Q9BYF1 | SARS-CoV-2 S-ACE2 complex | Angiotensin-converting enzyme 2 (E.C.3.4.17.23,3.4.17.-), Spike glycoprotein |
7DRV | Q9BYF1 | Structural basis of SARS-CoV-2-closely-related bat coronavirus RaTG13 to hACE2 | |
7KJ3 | Q9BYF1 | SARS-CoV-2 Spike Glycoprotein with two ACE2 Bound | Spike glycoprotein |
7A92 | Q9BYF1 | Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement) | Spike glycoprotein |
7FEM | Q9BYF1 | SARS-CoV-2 B.1.1.7 S-ACE2 complex | |
7RPV | Q9BYF1 | Crystal structure of affinity-enhancing and catalytically inactive ACE2 in complex with SARS-CoV-2 RBD | |
7SN0 | Q9BYF1 | Crystal structure of spike protein receptor binding domain of escape mutant SARS-CoV-2 from immunocompromised patient (d146*) in complex with human receptor ACE2 | |
7EFP | Q9BYF1 | Structure of SARS-CoV-2 spike receptor-binding domain in complex with high affinity ACE2 mutant (S19W,N330Y) | |
7SY8 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K,K417T mutant spike protein ectodomain bound to human ACE2 ectodomain (focused refinement of RBD and ACE2) | |
7YDI | Q9BYF1 | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2, focused refinement of RBD region | |
7YEG | Q9BYF1 | SARS-CoV-2 Spike (6P) in complex with 3 R1-32 Fabs and 3 ACE2 | |
8DLN | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
8DLU | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 | |
8DLV | Q9BYF1 | Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with human ACE2 (focused refinement of RBD and ACE2) | |
8IF2 | Q9BYF1 | Crystal structure of the receptor binding domain of SARS-CoV-2 Omicron BQ.1.1 variant spike protein in complex with its receptor ACE2 | |
8I91 | Q9BYF1 | ACE2-SIT1 complex bound with proline | |
8I92 | Q9BYF1 | ACE2-B0AT1 complex bound with glutamine | |
8I93 | Q9BYF1 | ACE2-B0AT1 complex bound with methionine | |
8QSQ | Q9BYF1 | Locally refined SARS-CoV-2 BA-2.86 Spike receptor binding domain (RBD) complexed with angiotensin converting enzyme 2 (ACE2) | |
7WGB | Q9BYF1 | Neutral Omicron Spike Trimer in complex with ACE2 | |
7WGC | Q9BYF1 | Neutral Omicron Spike Trimer in complex with ACE2. | |
7DQA | Q9BYF1 | Cryo-EM structure of SARS-CoV2 RBD-ACE2 complex | |
7SY3 | Q9BYF1 | Cryo-EM structure of the SARS-CoV-2 D614G,N501Y,E484K mutant spike protein ectodomain bound to human ACE2 ectodomain (global refinement) |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024